Expression of concern

Notoginsenoside R1 up-regulates microRNA-132 to protect human lung fibroblast MRC-5 cells from lipopolysaccharide-caused injury

Expression of concern Details

Nature of Retraction:

Expression of concern

Citations (23)

23
Total Citations
12
Post-Retraction
(52.2%)
11
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
4 Within 1 year
6 After 2+ years
1274 Days since retraction (latest)
Pharmacokinetics and Biological Activities of Notoginsenoside R1: A Systematical Review
Chao Wen, Xiaofei Liao, Xinyun Ye et al. (4 authors)
The American Journal of Chinese Medicine
Published: Jan 2025
2 citations
1274 days after retraction
Pre-treatment with notoginsenoside R1 from Panax notoginseng protects against high-altitude-induced pulmonary edema by inhibiting pyroptosis through the NLRP3/caspase-1/GSDMD pathway
Demei Huang, Yilan Wang, Caixia Pei et al. (9 authors)
Biomedicine & Pharmacotherapy Open Access
Published: Sep 2024
3 citations
1153 days after retraction
Investigating the Impact of IL-6 and CXCL8 on Neurodegeneration and Cognitive Decline in Alzheimer's Disease
Dongdong Jin, Min Zhang, Lei Shi et al. (4 authors)
The International Journal of Neuropsychopharmacology Open Access
Published: Sep 2024
1 citation
1126 days after retraction
Communication between alveolar macrophages and fibroblasts via the TNFSF12-TNFRSF12A pathway promotes pulmonary fibrosis in severe COVID-19 patients
Lei Guo, Qiong Chen, Mengying Xu et al. (5 authors)
Journal of Translational Medicine Open Access
Published: Jul 2024
4 citations
1090 days after retraction
Notoginsenoside R1 restrains the proliferation and migration of airway smooth muscle cells isolated from rats with chronic obstructive pulmonary disease
Xiaoyong Li, Kai Chen, Xuefei Shi et al. (6 authors)
Inhalation Toxicology
Published: Feb 2024
937 days after retraction
Panax notoginseng saponin R1 improves glucocorticoid-inhibited airway epithelium repair via glucocorticoid receptor β
Lili Yang, Maozhu Xu, Linghuan Zhang et al. (9 authors)
International Immunopharmacology Open Access
Published: Dec 2023
2 citations
864 days after retraction
The inhibitory effect of quercetin-3-glucuronide on pulmonary injury in vitro and in vivo
Pei-Rong Yua, Jen‐Ying Hsu, Chiao-Yun Tseng et al. (5 authors)
Journal of Food and Drug Analysis Open Access
Published: Jun 2023
11 citations
680 days after retraction
Evaluation of antioxidant activity of NG-R1 saponin against bacterial cells in induced oxidative stress – a preliminary study
Anna Lichota, Monika Sienkiewicz
Annals of Agricultural and Environmental Medicine Open Access
Published: Mar 2023
1 citation
575 days after retraction
Abnormal expression of lncRNA CASC9 in pneumonia children with respiratory failure and its feasible value for the clinical diagnosis of patients
Chi Zhou, Danfei Wu
Cell Cycle Open Access
Published: May 2022
3 citations
288 days after retraction
Notoginsenoside R1 alleviates spinal cord injury through the miR-301a/KLF7 axis to activate Wnt/β-catenin pathway
Zhi Tang, Chunhua Yang, Zhengwen He et al. (5 authors)
Open Medicine Open Access
Published: Jan 2022
6 citations
150 days after retraction
Protective effects of the notoginsenoside R1 on acute lung injury by regulating the miR-128-2-5p/Tollip signaling pathway in rats with severe acute pancreatitis
Ju He, Ming-wei Liu, Zhiyi Wang et al. (4 authors)
Innate Immunity Open Access
Published: Jan 2022
13 citations
150 days after retraction
Notoginsenoside R1 attenuates oxidative stress‐induced osteoblast dysfunction through JNK signalling pathway
Xumin Li, Haiyan Lin, Xiaorong Zhang et al. (10 authors)
Journal of Cellular and Molecular Medicine Open Access
Published: Nov 2021
50 citations
104 days after retraction
Protective effects of notoginsenoside R1 on acute lung injury in rats with sepsis
Bo Cao, Zhaoxia Xu, Chang Liu et al. (8 authors)
Annals of Translational Medicine Open Access
Published: Jun 2021
10 citations
64 days before retraction
Notoginsenoside R1 induces DNA damage via PHF6 protein to inhibit cervical carcinoma cell proliferation
Ting Cai, Wenquan Wu, Longhua Guo et al. (8 authors)
Molecular Medicine Reports Open Access
Published: Feb 2021
8 citations
184 days before retraction
Knockdown of lncRNA LINC00707 alleviates LPS-induced injury in MRC-5 cells by acting as a ceRNA of miR-223-5p
Xiequn Zou, Cheng Gao, Rong Shang et al. (5 authors)
Bioscience Biotechnology and Biochemistry
Published: Jan 2021
10 citations
187 days before retraction
Ginsenoside Rb1 Alleviates Lipopolysaccharide-Induced Inflammatory Injury by Downregulating miR-222 in WI-38 Cells
Erhu Wei, Xiao Fang, Peisheng Jia et al. (8 authors)
Cell Transplantation Open Access
Published: Jan 2021
17 citations
215 days before retraction
Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm
Michel Desjarlais, Maëlle Wirth, Isabelle Lahaie et al. (7 authors)
Frontiers in Pharmacology Open Access
Published: Dec 2020
18 citations
236 days before retraction
Dihydroquercetin attenuates lipopolysaccharide-induced acute lung injury through modulating FOXO3-mediated NF-κB signaling via miR-132–3p
Jianhua Liu, Liang Cao, Changhong Zhang et al. (6 authors)
Pulmonary Pharmacology & Therapeutics
Published: Aug 2020
24 citations
354 days before retraction
<p>Focus on Notoginsenoside R1 in Metabolism and Prevention Against Human Diseases</p>
Hai Liu, Jianqiong Yang, Wanqing Yang et al. (8 authors)
Drug Design Development and Therapy Open Access
Published: Feb 2020
67 citations
550 days before retraction
Long non-coding RNA NKILA weakens TNF-α-induced inflammation of MRC-5 cells by miR-21 up-regulation
Dandan Wang, Jiajie Zhang, Yan Sun et al. (5 authors)
Artificial Cells Nanomedicine and Biotechnology Open Access
Published: Jan 2020
14 citations
581 days before retraction
RETRACTED: Notoginsenoside R1 suppresses miR-301a via NF-κB pathway in lipopolysaccharide-treated ATDC5 cells
Yan Dong, Xia Yan, Xirui Yang et al. (7 authors)
Experimental and Molecular Pathology
Published: Dec 2019
8 citations
602 days before retraction
<i>Retracted:</i> Gastrodin relieves inflammation injury induced by lipopolysaccharides in MRC‐5 cells by up‐regulation of miR‐103
Zhuona Xi, Yahong Qiao, Jifang Wang et al. (8 authors)
Journal of Cellular and Molecular Medicine Open Access
Published: Nov 2019
15 citations
618 days before retraction
<i>Retracted</i>:Propofol exerts anticancer activity on hepatocellular carcinoma cells by raising lncRNA DGCR5
Yan Sun, Hai Sun
Journal of Cellular Physiology Open Access
Published: Sep 2019
14 citations
685 days before retraction
Quick Stats
Total Citations: 23
Years Since Retraction: 4.3 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Methyl helicterilate ameliorates alcohol-induced hepatic fi…
International Immunopharmacology • 13 citations
Modulation of cytokine and β-defensin 2 expressions in huma…
International Immunopharmacology • 25 citations
Cyanorona-20: The first potent anti-SARS-CoV-2 agent
International Immunopharmacology • 28 citations
Oroxylin A inhibits carcinogen-induced skin tumorigenesis t…
International Immunopharmacology • 24 citations
MiR-92b-3p ameliorates inflammation and autophagy by target…
International Immunopharmacology • 24 citations